文献速递类风湿关节炎其他结缔组织病

类风湿关节炎相关与特发性炎性肌病相关间质性肺病肺泡T细胞共抑制分子表达差异

Distinct Expression of Coinhibitory Molecules on Alveolar T Cells in Patients With Rheumatoid Arthritis-Associated and Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease.
PubMed 文献 · Arthritis Rheumatol · 2021-02-15

OBJECTIVE: To identify immunologic factors in the lungs of patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) and patients with idiopathic inflammatory myopathy-associated ILD (IIM-ILD) and to examine their pathologic mechanisms.…

要点

  • BAL液T细胞共表达CTLA-4、PD-1、TIM-3和LAG-3,外周血T细胞仅表达PD-1。
  • RA-ILD特征为CTLA-4+PD-1+CD4+T细胞,IIM-ILD特征为CTLA-4+PD-1+TIM-3+CD8+T细胞。
  • RA-ILD和IIM-ILD患者肺泡巨噬细胞可诱导T细胞PD-1和TIM-3表达增高。

核心结论

  • RA-ILD与IIM-ILD患者肺泡T细胞共抑制分子表达模式不同,RA-ILD中T细胞PD-1和IIM-ILD中CD8+T细胞TIM-3可能是疾病过程的关键因素。

研究设计与样本

  • 采用健康人外周血初始CD4+T细胞与肺泡巨噬细胞共培养及RNA测序分析肺泡巨噬细胞功能。

主要发现

  • BAL液T细胞共表达CTLA-4、PD-1、TIM-3和淋巴细胞激活基因3蛋白(从多到少),而外周血T细胞仅表达PD-1。
  • RA-ILD以CTLA-4+PD-1+CD4+T细胞为特征,IIM-ILD以CTLA-4+PD-1+TIM-3+CD8+T细胞为特征。
  • BAL液PD-1+CD4+T细胞极少表达CXCR5,其水平与浆母细胞和浆细胞水平相关(ρ=0.57,P=0.006)。
  • RA-ILD和IIM-ILD患者肺泡巨噬细胞诱导T细胞PD-1和TIM-3表达增多(P<0.05)。
  • RNA测序显示RA-ILD患者肺泡巨噬细胞PD配体1/2基因较药物性ILD显著下调。

临床怎么用

  • 评估BAL液T细胞共抑制分子表达可能对RA-ILD和IIM-ILD具有临床实用价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify immunologic factors in the lungs of patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) and patients with idiopathic inflammatory myopathy-associated ILD (IIM-ILD) and to examine their pathologic mechanisms. METHODS: Eleven patients with RA-ILD, 16 with IIM-ILD, 6 with drug-induced ILD (DI-ILD), and 8 healthy controls were enrolled. Peripheral blood (PB) and bronchoalveolar lavage (BAL) fluid were immunophenotyped by flow cytometry. Alveolar macrophages (AMs) were analyzed by coculture assay with PB naive CD4+ T cells from healthy individuals and RNA sequencing. RESULTS: Several coinhibitory molecules were coexpressed on BAL fluid T cells (CTLA-4, programmed death 1 [PD-1], T cell immunoglobulin and mucin domain-containing protein 3 [TIM-3], and lymphocyte activation gene 3 protein, from most to least), whereas only PD-1 was expressed on PB T cells. CTLA-4+PD-1+CD4+ T cells were characteristic of RA-ILD, whereas CTLA-4+PD-1+TIM-3+CD8+ T cells were characteristic of IIM-ILD. BAL fluid PD-1+CD4+ T cells rarely expressed CXCR5, but their levels correlated with levels of plasmablasts and plasma cells (ρ = 0.57, P = 0.006), indicating that most of them would be considered peripheral helper T cells. In coculture experiments, AMs from patients with RA-ILD and IIM-ILD induced more PD-1 and TIM-3 on T cells (P < 0.05), suggesting that coinhibitory molecule expression on BAL fluid T cells was partly due to AMs. RNA sequencing showed significant down-regulation of PD ligand 1/2 genes in AMs from patients with RA-ILD compared to those with DI-ILD. CONCLUSION: We have identified differences in coinhibitory molecule expression between patients with RA-ILD and those with IIM-ILD. PD-1 on T cells in RA-ILD and TIM-3 on CD8+ T cells in IIM-ILD might be key factors in the disease process. Evaluation of coinhibitory molecules on BAL fluid T cells could be clinically useful.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Nakazawa M, Suzuki K, Takeshita M, et al. Distinct Expression of Coinhibitory Molecules on Alveolar T Cells in Patients With Rheumatoid Arthritis-Associated and Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2021. PMID: 33038063. doi:10.1002/art.41554

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。